SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001829126-24-003876
Filing Date
2024-05-30
Accepted
2024-05-30 16:30:30
Documents
13
Period of Report
2024-03-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A opgeninc_8ka.htm   iXBRL 8-K/A 41805
  Complete submission text file 0001829126-24-003876.txt   218770

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE opgn-20240325.xsd EX-101.SCH 3006
3 XBRL LABEL FILE opgn-20240325_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE opgn-20240325_pre.xml EX-101.PRE 22353
16 EXTRACTED XBRL INSTANCE DOCUMENT opgeninc_8ka_htm.xml XML 4478
Mailing Address 9717 KEY WEST AVENUE SUITE 100 ROCKVILLE MD 20850
Business Address 9717 KEY WEST AVENUE SUITE 100 ROCKVILLE MD 20850 301-869-9683
OPGEN INC (Filer) CIK: 0001293818 (see all company filings)

IRS No.: 061614015 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-37367 | Film No.: 241005906
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)